{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:14:27Z","timestamp":1790144067277,"version":"4.0.1"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360920"],"award-info":[{"award-number":["82360920"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To explore the proteomic difference and mechanism in the dorsal raphe nucleus (DRN) of rats with body weight gain induced by long-term olanzapine administration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Thirty-six female Sprague-Dawley rats were randomly divided into two groups: an olanzapine treatment group (2.4\u00a0mg\/(kg\u00b7d) and a vehicle control group (0.5% sodium carboxymethyl cellulose). Both treatments were administrated via drinking water for 24 continuous weeks. On the last day of 24th week, DRN samples were collected for proteomic analysis, quantitative real-time reverse transcription polymerase chain reaction (qPCR), Western blot (WB) analysis and bioassays. Differentially expressed proteins related to olanzapine treatment were subjected to bioinformatics analysis. Target genes were selected based on proteomic data for validation using qPCR and WB. Oxidative stress and inflammatory reaction were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Body weight gain in the olanzapine group was significantly higher than in the control group starting from the week 18, exceeding 10% by week 24. Proteomic analysis identified 156 upregulated and 37 downregulated proteins in the DRN of the olanzapine-treated rats compared to the controls. KEGG analysis enriched these differentially expressed proteins into serotonergic, glutamatergic, and GABAergic synapses, alongside calcium signaling pathways related to olanzapine treatment. Protein-protein interaction (PPI) network analysis indicated that several olanzapine-associated differentially expressed proteins, including Ddc, Gchfr, Chrnb2, Tph2, Gad1, Grm1, Slc17a7, Gabra2, Gabra4, Gng3, Gng13, and Gnb4, were closely correlated to metabolic disorders. qPCR and WB confirmed that Tph2, the rate-limiting enzyme for 5-HT biosynthesis were significantly downregulated in the DRN of the olanzapine-treated rats (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.01) compared to the controls; Furthermore, both the mRNA and protein expression levels of key genes within the glutamatergic synaptic (\n                      <jats:italic>Grm1, Slc17a7<\/jats:italic>\n                      ), the GABAergic (\n                      <jats:italic>Gabbr2, Gng3<\/jats:italic>\n                      ), and the calcium signaling (\n                      <jats:italic>Ryr3, ITPR1<\/jats:italic>\n                      ) pathways were significantly upregulated (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.05). Elevated levels of reactive oxygen species (ROS), malondialdehyde (MDA), and interleukin-1 beta (IL-1\u03b2) in the DRN indicate that chronic olanzapine treatment induces oxidative stress and an inflammatory reaction.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Long-term olanzapine treatment induces significant body weight gain in female rats. This metabolic dysregulation is associated with alterations in multiple central pathways within the DRN, including the 5-HT synaptic signaling pathway.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1942856","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:49:11Z","timestamp":1790142551000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Regulation on the metabolic synaptic pathway in the dorsal raphe nucleus in a rat model chronic olanzapine-induced body weight gain"],"prefix":"10.3389","volume":"17","author":[{"given":"Ping","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Endocrinology, The Fifth People\u2019s Hospital of Jiujiang City","place":["Jiujiang, Jiangxi Province, China"]},{"name":"Experimental Center, The School of Basic Medicine, Jiujiang University","place":["Jiujiang, Jiangxi Province, China"]},{"name":"Affiliated Hospital of Jiujiang University","place":["Jiujiang, Jiangxi Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Fifth People\u2019s Hospital of Jiujiang City","place":["Jiujiang, Jiangxi Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Fifth People\u2019s Hospital of Jiujiang City","place":["Jiujiang, Jiangxi Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Fifth People\u2019s Hospital of Jiujiang City","place":["Jiujiang, Jiangxi Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Fifth People\u2019s Hospital of Jiujiang City","place":["Jiujiang, Jiangxi Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Fifth People\u2019s Hospital of Jiujiang City","place":["Jiujiang, Jiangxi Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingfang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Fifth People\u2019s Hospital of Jiujiang City","place":["Jiujiang, Jiangxi Province, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1111\/obr.12934","article-title":"Effects of antidepressant and antipsychotic use on weight gain: a systematic review","volume":"20","author":"Alonso-Pedrero","year":"2019","journal-title":"Obes. Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jaac.2014.08.009","article-title":"Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-na\u00efve patients","volume":"53","author":"Arango","year":"2014","journal-title":"J. Am. Acad. Child. Adolesc. Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/j.amjcard.2016.02.049","article-title":"Review of the ongoing story of appetite suppressants, serotonin pathway, and pulmonary vascular disease","volume":"117","author":"Bazan","year":"2016","journal-title":"Am. J. Cardiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"885","DOI":"10.2174\/1568026033452249","article-title":"5-HT2C receptor agonists as potential drugs for the treatment of obesity","volume":"3","author":"Bickerdike","year":"2003","journal-title":"Curr. Top. Med. Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.bbalip.2016.02.015","article-title":"Homeostatic regulation of the PI(4,5)P2-Ca(2+) signaling system at ER-PM junctions","volume":"1861","author":"Chang","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"B6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13578-023-01091-7","article-title":"Unraveling the serotonin Saga: from discovery to weight regulation and beyond - a comprehensive scientific review","volume":"13","author":"Conde","year":"2023","journal-title":"Cell. Biosci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00213-011-2555-2","article-title":"Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters","volume":"221","author":"Davey","year":"2012","journal-title":"Psychopharmacol. Berl."},{"key":"B8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/bs.pbr.2021.01.005","article-title":"CB1\/5-HT\/GABA interactions and food intake regulation","volume":"259","author":"Escart\u00edN P\u00e9REZ","year":"2021","journal-title":"Prog. Brain Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e20571","DOI":"10.1371\/journal.pone.0020571","article-title":"Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation","volume":"6","author":"Fern\u00f8","year":"2011","journal-title":"PLoS One"},{"key":"B10","doi-asserted-by":"publisher","first-page":"8671","DOI":"10.3390\/ijms22168671","article-title":"mTOR knockdown in the infralimbic Cortex evokes A depressive-like State in mouse","volume":"22","author":"Garro-Mart\u00edNEZ","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"174956","DOI":"10.1016\/j.ejphar.2022.174956","article-title":"The central melanocortin system as a treatment target for obesity and diabetes: a brief overview","volume":"924","author":"Goit","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/ijnp\/pyaa004","article-title":"Antipsychotic treatment effectiveness in first episode of psychosis: PAFIP 3-Year Follow-Up randomized clinical trials comparing Haloperidol, olanzapine, risperidone, aripiprazole, quetiapine, and ziprasidone","volume":"23","author":"G\u00f3MEZ-Revuelta","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"114885","DOI":"10.1016\/j.bbr.2024.114885","article-title":"Olanzapine attenuates 5-HT2cR and GHSR1a interaction to increase orexigenic hypothalamic NPY: implications for neuronal molecular mechanism of metabolic side effects of antipsychotics","volume":"463","author":"Liu","year":"2024","journal-title":"Behav. Brain Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12991-024-00532-y","article-title":"Clinical patterns of metabolic syndrome in young, clinically stable, olanzapine-exposed patients with schizophrenia","volume":"23","author":"Ma","year":"2024","journal-title":"Ann. Gen. Psychiatry"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1080\/14740338.2019.1674809","article-title":"Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia","volume":"18","author":"Marteene","year":"2019","journal-title":"Expert Opin. Drug Saf."},{"key":"B16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.coph.2011.02.007","article-title":"The role of serotonin receptors in the action of atypical antipsychotic drugs","volume":"11","author":"Meltzer","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12974-023-02923-6","article-title":"ASK1-K716R reduces neuroinflammation and white matter injury via preserving blood-brain barrier integrity after traumatic brain injury","volume":"20","author":"Meng","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/mp.2012.47","article-title":"Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents","volume":"17","author":"Miyamoto","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.cell.2017.06.045","article-title":"Identification of a brainstem circuit controlling feeding","volume":"170","author":"Nectow","year":"2017","journal-title":"Cell."},{"key":"B20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.67316\/jintb.v1.i2.18","article-title":"Neuro-metabolic disruption underlying olanzapine-induced obesity","volume":"1","author":"Pagi","year":"2026","journal-title":"J. Integr. Transl. Biomed."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1042\/BCJ20190410","article-title":"Calcium-induced dissociation of CIB1 from ASK1 regulates agonist-induced activation of the p38 MAPK pathway in platelets","volume":"476","author":"Patel","year":"2019","journal-title":"Biochem. J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s42255-025-01252-7","article-title":"GLP-2 prevents antipsychotics-induced metabolic dysfunction in mice","volume":"7","author":"Peng","year":"2025","journal-title":"Nat. Metab."},{"key":"B23","doi-asserted-by":"publisher","first-page":"106987","DOI":"10.1016\/j.psyneuen.2024.106987","article-title":"Olanzapine's effects on hypothalamic transcriptomics and kinase activity","volume":"163","author":"Pereira","year":"2024","journal-title":"Psychoneuroendocrinology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1161\/CIRCRESAHA.120.317768","article-title":"Inositol trisphosphate receptors and nuclear calcium in atrial fibrillation","volume":"128","author":"Qi","year":"2021","journal-title":"Circ. Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"102399","DOI":"10.1016\/j.ceca.2021.102399","article-title":"Ryanodine receptor-mediated Ca(2+) release and atlastin-2 GTPase activity contribute to IP(3)-induced dendritic Ca(2+) signals in primary hippocampal neurons","volume":"96","author":"Ram\u00edREZ","year":"2021","journal-title":"Cell. Calcium"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e110833","DOI":"10.15252\/embj.2022110833","article-title":"The MASTL\/PP2A cell cycle kinase-phosphatase module restrains PI3K-Akt activity in an mTORC1-dependent manner","volume":"42","author":"Sanz-Castillo","year":"2023","journal-title":"Embo J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1192\/bjp.bp.107.037184","article-title":"First-v. Second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis","volume":"192","author":"Smith","year":"2008","journal-title":"Br. J. Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s13258-022-01230-3","article-title":"PKC-\u03b2 modulates Ca(2+) mobilization through Stim1 phosphorylation","volume":"44","author":"Song","year":"2022","journal-title":"Genes Genomics"},{"key":"B29","doi-asserted-by":"publisher","first-page":"115449","DOI":"10.1016\/j.jep.2022.115449","article-title":"Processed product (Pinelliae Rhizoma Praeparatum) of Pinellia ternata (Thunb.) Breit. Alleviates the allergic airway inflammation of cold phlegm via regulation of PKC\/EGFR\/MAPK\/PI3K-AKT signaling pathway","volume":"295","author":"Tao","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"802581","DOI":"10.3389\/fpsyt.2021.802581","article-title":"Rewiring of the serotonin system in major depression","volume":"12","author":"Vahid-Ansari","year":"2021","journal-title":"Front. Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"117016","DOI":"10.1016\/j.jep.2023.117016","article-title":"Jiawei-xiaoyao pill elicits a rapid antidepressant effect, dependent on activating CaMKII\/mTOR\/BDNF signaling pathway in the hippocampus","volume":"318","author":"Zhang","year":"2024","journal-title":"J. Ethnopharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1942856\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:49:12Z","timestamp":1790142552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1942856\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":31,"alternative-id":["10.3389\/fphar.2026.1942856"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1942856","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"article-number":"1942856"}}